CURATIS N AG Total Assets

Latest as of June 2025: CHF54.52 Million CHF ≈ $68.93 Million USD

CURATIS N AG total assets. Based on the latest financial reports, CURATIS N AG (CURN) holds total assets worth CHF54.52 Million CHF (≈ $68.93 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see CURATIS N AG stock valuation for the company's overall valuation and market capitalisation.

Total Assets of CURATIS N AG (2002–2024)

Total assets of CURATIS N AG from 2002 to 2024. This chart illustrates how CURATIS N AG's total assets have evolved over time, based on quarterly financial data. See CURATIS N AG (CURN) share price today for real-time trading data and today's change.

CURATIS N AG - Asset Composition Analysis

CURATIS N AG Total Assets Breakdown (December 2024)

CURATIS N AG total assets breakdown as of December 2024. CURATIS N AG's total assets of CHF54.52 Million consist of 10.6% current assets and 89.4% non-current assets.

Asset Category	Amount (CHF)	% of Total Assets
Cash & Equivalents	CHF3.01 Million	5.4%
Accounts Receivable	CHF1.56 Million	2.8%
Inventory	CHF1.32 Million	2.4%
Property, Plant & Equipment	CHF0.00	0.0%
Intangible Assets	CHF49.38 Million	88.9%
Goodwill	CHF0.00	0.0%

Asset Composition Trend (2002–2024)

This chart illustrates how CURATIS N AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CURATIS N AG short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: CURATIS N AG's current assets represent 10.6% of total assets in 2024, a decrease from 36.2% in 2002.
Cash Position: Cash and equivalents constituted 5.4% of total assets in 2024, down from 6.5% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 88.0% of total assets, an increase from 3.0% in 2002.
Asset Diversification: The largest asset category is intangible assets at 88.9% of total assets.

CURATIS N AG Competitors by Total Assets

Key competitors of CURATIS N AG based on total assets are shown below.

Company	Country	Total Assets
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Galderma Group N SW:GALD	Switzerland	CHF12.88 Billion
Enzymatica publ AB ST:ENZY	Sweden	Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Walvax BioTech SHE:300142	China	CN¥10.50 Billion

CURATIS N AG - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.50	0.92	1.09
Quick Ratio	1.07	0.72	1.09
Cash Ratio	0.62	0.51	0.00
Working Capital	CHF1.65 Million	CHF-555.00K	CHF17.00K

CURATIS N AG - Advanced Valuation Insights

This section examines the relationship between CURATIS N AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.06
Latest Market Cap to Assets Ratio	1.61
Asset Growth Rate (YoY)	46180.0%
Total Assets	CHF55.54 Million
Market Capitalization	$89.64 Million USD

Valuation Analysis

Above Book Valuation: The market values CURATIS N AG's assets above their book value (1.61x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: CURATIS N AG's assets grew by 46180.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for CURATIS N AG (2002–2024)

The table below shows the annual total assets of CURATIS N AG from 2002 to 2024.

Year	Total Assets	Change
2024-12-31	CHF55.54 Million ≈ $70.21 Million	+46180.00%
2023-12-31	CHF120.00K ≈ $151.71K	-99.15%
2022-12-31	CHF14.05 Million ≈ $17.76 Million	+10227.94%
2021-12-31	CHF136.00K ≈ $171.94K	+7.09%
2020-12-31	CHF127.00K ≈ $160.56K	-94.16%
2019-12-31	CHF2.17 Million ≈ $2.75 Million	-0.73%
2018-12-31	CHF2.19 Million ≈ $2.77 Million	-67.24%
2017-12-31	CHF6.68 Million ≈ $8.45 Million	-5.70%
2016-12-31	CHF7.09 Million ≈ $8.96 Million	-11.01%
2015-12-31	CHF7.97 Million ≈ $10.07 Million	-19.95%
2014-12-31	CHF9.95 Million ≈ $12.58 Million	-14.75%
2013-12-31	CHF11.67 Million ≈ $14.76 Million	-39.27%
2012-12-31	CHF19.22 Million ≈ $24.30 Million	+56.62%
2011-12-31	CHF12.27 Million ≈ $15.52 Million	-8.15%
2010-12-31	CHF13.36 Million ≈ $16.89 Million	+61.52%
2009-12-31	CHF8.27 Million ≈ $10.46 Million	+62.45%
2008-12-31	CHF5.09 Million ≈ $6.44 Million	-45.61%
2007-12-31	CHF9.36 Million ≈ $11.84 Million	-32.69%
2006-12-31	CHF13.91 Million ≈ $17.58 Million	-59.87%
2005-12-31	CHF34.66 Million ≈ $43.82 Million	-41.97%
2004-12-31	CHF59.73 Million ≈ $75.51 Million	-16.27%
2003-12-31	CHF71.33 Million ≈ $90.18 Million	+3.32%
2002-12-31	CHF69.04 Million ≈ $87.29 Million	--

About CURATIS N AG

SW:CURN Switzerland Drug Manufacturers - Specialty & Generic

Market Cap

$111.05 Million

CHF87.84 Million CHF

Market Cap Rank

#19429 Global

#189 in Switzerland

Share Price

CHF17.05

Change (1 day)

-2.01%

52-Week Range

CHF11.30 - CHF26.00

All Time High

CHF891.52